Compositions and methods for transdermal oxybutynin therapy

  • US 7,029,694 B2
  • Filed: 11/01/2002
  • Issued: 04/18/2006
  • Est. Priority Date: 04/26/2000
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating with oxybutynin a subject having overactive bladder, while minimizing an anticholinergic or antimuscarinic adverse drug experience associated with said oxybutynin treatment therapy comprising the step of:

  • administering as a topical gel, a composition comprising oxybutynin to a subject to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5;

    1 to about 5;

    1, wherein the topical gel optionally includes a permeation enhancer.

View all claims

    Thank you for your feedback